Patents Assigned to EMP Pharma GmbH
  • Method for the preparation of a levothyroxine solution
    Patent number: 9050307
    Abstract: Levothyroxine, also known as L-thyroxine, synthetic T4, or 3,5,3?,5?-tetraiodo-L-thyronine, CAS number 51-48-9, is a synthetic form of thyroxine, used as a hormone substitute for patients with thyroid conditions. The invention relates to a method for the preparation of an oral levothyroxine composition. The method according to the invention results in liquid levothyroxine formulations that have improved storage stability compared to known liquid levothyroxine formulations.
    Type: Grant
    Filed: March 10, 2011
    Date of Patent: June 9, 2015
    Assignee: EMP Pharma GmbH
    Inventors: Yannis Psarrakis, Konstantinos I. Lioumis
  • METHOD FOR THE PREPARATION OF A LEVOTHYROXINE SOLUTION
    Publication number: 20140073695
    Abstract: Levothyroxine, also known as L-thyroxine, synthetic T4, or 3,5,3?,5?-tetraiodo-L-thyronine, CAS number 51-48-9, is a synthetic form of thyroxine, used as a hormone substitute for patients with thyroid conditions. The invention relates to a method for the preparation of an oral levothyroxine composition. The method according to the invention results in liquid levothyroxine formulations that have improved storage stability compared to known liquid levothyroxine formulations.
    Type: Application
    Filed: March 10, 2011
    Publication date: March 13, 2014
    Applicant: EMP Pharma GmbH
    Inventors: Yannis Psarrakis, Konstantinos I. Lioumis